Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Luveris
Active Ingredient: Lutropin alfa, rch 75IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Laboratoires Serono SA, Aubonne, Switzerland
Note: This renewed consent is valid for two years from the date of publication of this notice.
Dated this 23rd day of October 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).